https://www.selleckchem.com/products/hg6-64-1.html
The sustained-release formulation of meloxicam (MSR) is a compounded NSAID that may provide pain relief for as long as 72 h after administration. MSR injection-site skin reactions have occurred in several species but have not previously been observed in mice. We investigated the development and progression of localized skin reactions after a single injection of MSR in CrlCD1(ICR), C57BL/6J, and BALB/cJ mice. Each mouse received a subcutaneous injection of MSR (n = 6, standard-formulation meloxicam (MEL; n = 24) or saline (control; SC
Like
Comment
Share
